What is an NAD (nicotinamide adenine dinucleotide) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is an NAD Test?

An NAD test measures the concentration of nicotinamide adenine dinucleotide (NAD+) in biological samples—most commonly blood plasma or cells—to assess cellular energy metabolism, mitochondrial function, and overall metabolic health. 1

What NAD+ Is and Why It Matters

NAD+ is a critical coenzyme present in all living cells that serves multiple essential functions 1:

  • Energy metabolism: NAD+ acts as the principal electron donor in the mitochondrial respiratory chain, being oxidized from NADH to NAD+ at complex I to drive ATP production 1
  • DNA repair: NAD+ serves as a cofactor for poly (ADP-ribose) polymerases (PARP), which carry out DNA base excision repair processes 1
  • Cellular signaling: NAD+ is consumed by sirtuins and PARP isozymes that regulate gene expression and cellular homeostasis 1
  • Redox balance: The NAD+/NADH ratio reflects cellular redox status and metabolic activity 1

Clinical significance: Age-related decline in cellular NAD+ levels has been demonstrated in both animal models and humans, with significant decreases in men (P = 0.001; r = -0.706) and women (P = 0.01; r = -0.537) 1. This depletion is associated with increased oxidative stress, mitochondrial dysfunction, and decreased ATP production 1.

Types of NAD Testing

Extracellular NAD+ (eNAD+) Testing

  • Sample type: Blood plasma or serum 2, 3
  • Concentration range: Approximately 0.25 μM in plasma—roughly 500 times lower than intracellular levels 3
  • Clinical relevance: Extracellular NAD+ has been associated with multiple systemic diseases and aging processes 2

Intracellular NAD+ (iNAD+) Testing

  • Sample type: Peripheral blood mononuclear cells or tissue samples 3
  • Concentration range: Approximately 131.8 ± 27.4 μM in cells 3
  • Clinical relevance: Reflects cellular metabolic capacity and mitochondrial function 1

Testing Methodologies

High-Performance Liquid Chromatography (HPLC)

HPLC represents the gold standard for NAD+ quantification, providing accurate, reliable, and reproducible results 4. This method enables precise analysis of pathophysiological changes in NAD+ levels both in vitro and in vivo 4.

Enzymatic Cycling Assays

  • Mechanism: Two-step enzymatic cycling reaction based on alcohol dehydrogenase 2
  • Sensitivity: Ranges from low micromolar to low nanomolar domain 2
  • Advantages: Suitable for high-throughput screening of extracellular NAD+ levels 2
  • Alternative: Commercially available enzymatic assays (e.g., Promega's NAD/NADH-Glo™ Assay) 1

Autofluorescence Detection

  • Principle: NADH and NADPH autofluoresce in their reduced state 1
  • Excitation/emission: 340-360 nm excitation, ~450 nm emission 1
  • Limitation: Requires UV lasers and can be phototoxic to cells 1
  • Application: Primarily used in research settings for cellular NAD(P)H measurement 1

Mass Spectrometry

  • Method: LC-MS provides highly accurate quantification 1
  • Advantage: Can measure ATP:ADP and ATP:AMP ratios, which are more biologically informative than ATP alone 1

Critical Pre-Analytical Considerations

Pre-analytical processing significantly impacts eNAD+ measurement accuracy and must be standardized 3:

Factors That DO NOT Significantly Affect eNAD+:

  • Sample storage at 4°C for up to 120 minutes 3
  • Temperature variations (0° to 25°C) 3
  • Cannula sizes for blood collection 3
  • Tourniquet times (0-120 seconds) 3

Factors That DO Significantly Affect eNAD+:

  • Centrifugation duration: Prolonged centrifugation (>5 minutes) significantly decreases eNAD+ levels (p < 0.05) 3
  • Centrifuge braking: Faster braking mode (<4 minutes) results in significant eNAD+ decrease (p < 0.05) 3
  • Extraction buffer: For enzymatic assays, detergent (e.g., 0.05% Triton X-100) must be included to prevent NADPH oxidation during extraction 1

Clinical Correlations:

  • C-reactive protein (CRP): Negatively correlated with eNAD+ (n = 33; r = -0.451; p = 0.020) 3
  • Hemoglobin: Positively correlated with eNAD+ (n = 33; r = 0.482; p = 0.005) 3
  • Lactate dehydrogenase: No significant correlation with eNAD+ (n = 33; r = -0.397; p = 0.102), suggesting cell lysis is not a major confounding factor 3

Clinical Applications

Assessment of Vitamin B3 Status

NAD+ measurement serves as a functional indicator of vitamin B3 (niacin/nicotinamide) sufficiency, as these are precursors for NAD+ synthesis 1. The urinary output of associated metabolites represents the only universally accepted method for vitamin B3 status assessment 1.

Monitoring Therapeutic Interventions

Recent clinical trials have demonstrated that NAD+ supplementation can improve cardiac function in heart failure patients, with significant LVEF improvement (45.44 ± 8.55% vs. 42.44 ± 9.09%, p = 0.024) 5. NAD+ testing enables monitoring of therapeutic response 5.

Age-Related Decline Assessment

NAD+ testing can identify age-related metabolic dysfunction, as NAD+ levels decline significantly with aging and correlate with increased PARP activation in men (P ≤ 0.0003; r = -0.639) and declined SIRT1 activity (P ≤ 0.007) 1.

Important Caveats

  • Sub-acute NAD+ deficiency is poorly characterized due to variable and non-specific symptoms including weakness, fatigue, anxiety, and depression 1
  • Sample handling is critical: Even minor NADPH degradation can result in substantial mismeasurement of NADP+ when determined by subtraction 1
  • Matrix effects: Albumin-modified simulated body fluid should be used as standard matrix to optimize enzymatic activity 2
  • Storage stability: Long-term storage stability of extracellular NAD+ in frozen plasma has been confirmed, but standardized protocols must be followed 2, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.